DGX Quest Diagnostics Earnings and EPS analysis

EPS in 2026 (TTM): $9.17

Last Report Period Date: Mar 31, 2026

As of June 2026, according to Quest Diagnostics's current financial statements, the company's 12-month EPS is $9.17. For the year 2025, the company recorded an earnings per share (EPS) of $8.87, which marks an increase compared to its EPS of $7.78 in 2024. Quest Diagnostics's earnings per share for the quarterly report ending on Mar 31, 2026 reached $2.27.

The annual EPS for the year 2025 was $8.87, an increase of 14% from $7.78 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $2.27, showing a 15.2% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $9.17. For the year 2024, the yearly earnings per share was $7.78, marking an increase of 2.5% from 2023.

During the last 12 months, Quest Diagnostics has seen an EPS growth of 15.2% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 3.1% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of -3.5%. A 10-year view shows that DGX has seen an average EPS growth of 6.1% per year.